Pliant Therapeutics Inc. (PLRX)
NASDAQ: PLRX
· Real-Time Price · USD
1.54
-0.03 (-2.22%)
At close: Aug 15, 2025, 3:59 PM
1.54
-0.32%
After-hours: Aug 15, 2025, 05:57 PM EDT
Pliant Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 2.27M | 2.27M | 2.27M | 4.84M | n/a | 248K | 1.58M | -1.29M | 5.03M | 9.77M | 9.69M | 9.72M | 9.85M | 6.65M | 7.57M | 10.04M | 13.24M | 15.05M |
Cost of Revenue | 2.56M | 2.74M | 2.8M | 2.13M | 2.64M | 3.13M | 3.67M | 4.26M | 4.25M | 4.04M | 3.68M | 4.71M | 4.08M | 3.19M | 2.49M | 400K | n/a | n/a |
Gross Profit | -292K | -467K | -532K | 2.71M | 1.03M | 796K | 1.58M | -1.88M | 779K | 5.72M | 6M | 5M | 5.76M | 3.46M | 5.08M | 9.64M | 13.24M | 15.05M |
Operating Income | -219.86M | -234.91M | -228.37M | -222.08M | -207.75M | -194.44M | -184.15M | -174.51M | -158.77M | -141.08M | -127.2M | -114.4M | -109.56M | -102.83M | -97.53M | -91.95M | -81.5M | -75.57M |
Interest Income | 13.12M | 18.77M | 21.09M | 22.91M | 24.3M | 25.1M | 24.08M | 20.48M | 15.6M | 9.42M | 4.67M | 2.08M | 516K | 320K | 272K | 290K | 349K | 387K |
Pretax Income | -206.96M | -219.51M | -210.3M | -201.68M | -185.41M | -170.74M | -161.34M | -155.29M | -144.41M | -132.77M | -123.32M | -112.79M | -109.22M | -102.51M | -97.26M | -91.76M | -81.25M | -75.42M |
Net Income | -206.96M | -219.51M | -210.3M | -201.68M | -185.41M | -170.74M | -151.93M | -145.43M | -131.89M | -120.25M | -119.98M | -109.91M | -109M | -102.28M | -97.26M | -91.76M | -81.25M | -75.42M |
Selling & General & Admin | 57.68M | 59.31M | 59.05M | 58.38M | 59.47M | 59.02M | 57.93M | 58.33M | 51.8M | 45.52M | 39.95M | 33.54M | 32.39M | 29.57M | 27.56M | 25.34M | 22.26M | 19.82M |
Research & Development | 162.18M | 174.98M | 168.18M | 162.1M | 146.69M | 134.69M | 127.33M | 119.73M | 112M | 105.33M | 96.94M | 90.57M | 87.02M | 79.9M | 77.55M | 76.65M | 72.48M | 70.8M |
Other Expenses | -447K | n/a | n/a | 464K | 464K | 464K | 464K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -97K | -42K | -178K |
Operating Expenses | 219.41M | 234.29M | 227.23M | 220.95M | 206.62M | 194.18M | 185.72M | 178.05M | 163.8M | 150.85M | 136.88M | 124.12M | 119.41M | 109.47M | 105.11M | 101.99M | 94.74M | 90.63M |
Interest Expense | 3.32M | 3.38M | 3.02M | 2.51M | 1.95M | 1.4M | 1.27M | 1.26M | 1.25M | 1.1M | 791K | 474K | 173K | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 219.86M | 234.91M | 228.37M | 222.08M | 207.75M | 194.69M | 185.72M | 178.05M | 163.8M | 150.85M | 136.88M | 124.12M | 119.41M | 109.47M | 105.11M | 101.99M | 94.74M | 90.63M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | -9.4M | -9.86M | -12.52M | -12.26M | -3.07M | -2.62M | 35K | -264K | -42K | -42K | -30K | -111K |
Shares Outstanding (Basic) | 61.39M | 61.22M | 60.54M | 60.73M | 60.38M | 60.18M | 59.9M | 59.69M | 59.17M | 56.06M | 48.78M | 46.8M | 36.17M | 36.03M | 36.02M | 35.91M | 35.67M | 35.65M |
Shares Outstanding (Diluted) | 61.39M | 61.22M | 60.54M | 60.73M | 60.38M | 60.18M | 59.9M | 59.69M | 59.17M | 56.06M | 48.78M | 46.8M | 36.17M | 36.12M | 36.02M | 35.91M | 35.75M | 35.65M |
EPS (Basic) | -3.4 | -3.61 | -3.47 | -3.34 | -3.09 | -2.87 | -2.59 | -2.61 | -2.51 | -2.63 | -2.9 | -2.87 | -3.02 | -2.84 | -2.71 | -2.57 | -2.29 | -3.04 |
EPS (Diluted) | -3.4 | -3.61 | -3.47 | -3.34 | -3.09 | -2.87 | -2.59 | -2.61 | -2.51 | -2.63 | -2.9 | -2.87 | -3.02 | -2.84 | -2.71 | -2.57 | -2.29 | -3.04 |
EBITDA | -201.76M | -214.08M | -205.16M | -197.04M | -180.81M | -166.22M | -156.39M | -149.79M | -139.25M | -128.12M | -119.35M | -109.81M | -106.95M | -100.84M | -96M | -90.49M | -80.09M | -74.22M |
EBIT | -203.64M | -216.14M | -207.28M | -199.17M | -183.45M | -169.34M | -160.07M | -154.05M | -143.49M | -131.99M | -122.86M | -112.69M | -109.19M | -102.72M | -97.53M | -91.95M | -81.5M | -75.57M |
Depreciation & Amortization | 1.89M | 2.06M | 2.13M | 2.13M | 2.64M | 3.13M | 3.67M | 4.26M | 4.25M | 4.04M | 3.68M | 4.71M | 4.08M | 3.59M | 3.25M | 1.51M | 1.44M | 1.36M |